These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 22035630)

  • 1. Platelet dysfunction in vascular pathologies and how can it be treated.
    Alexandru N; Popov D; Georgescu A
    Thromb Res; 2012 Feb; 129(2):116-26. PubMed ID: 22035630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulators of platelet function in aging.
    Iyer KS; Dayal S
    Platelets; 2020 May; 31(4):474-482. PubMed ID: 31524038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.
    Jennings LK
    Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Platelet inhibition and activation. Mechanisms and clinical implications].
    Alberio L; Clemetson KJ
    Herz; 2005 May; 30(3):176-80. PubMed ID: 15902367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond.
    Xu XR; Zhang D; Oswald BE; Carrim N; Wang X; Hou Y; Zhang Q; Lavalle C; McKeown T; Marshall AH; Ni H
    Crit Rev Clin Lab Sci; 2016 Dec; 53(6):409-30. PubMed ID: 27282765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential therapeutic targeting of platelet-mediated cellular interactions in atherosclerosis and inflammation.
    Nagy B; Miszti-Blasius K; Kerenyi A; Clemetson KJ; Kappelmayer J
    Curr Med Chem; 2012; 19(4):518-31. PubMed ID: 22204330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelets in vascular disease.
    Reinhart WH
    Clin Hemorheol Microcirc; 2013; 53(1-2):71-9. PubMed ID: 22954635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelets as therapeutic targets to prevent atherosclerosis.
    Nording H; Baron L; Langer HF
    Atherosclerosis; 2020 Aug; 307():97-108. PubMed ID: 32653088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelets in rheumatic diseases: friend or foe?
    Gasparyan AY; Ayvazyan L; Pretorius E; Kitas GD
    Curr Pharm Des; 2014; 20(4):552-66. PubMed ID: 23565634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet Function in Cardiovascular Disease: Activation of Molecules and Activation by Molecules.
    Khodadi E
    Cardiovasc Toxicol; 2020 Feb; 20(1):1-10. PubMed ID: 31784932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelets as cellular effectors of inflammation in vascular diseases.
    Rondina MT; Weyrich AS; Zimmerman GA
    Circ Res; 2013 May; 112(11):1506-19. PubMed ID: 23704217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Our expanding view of platelet functions and its clinical implications.
    Ombrello C; Block RC; Morrell CN
    J Cardiovasc Transl Res; 2010 Oct; 3(5):538-46. PubMed ID: 20661787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of platelets in the pathophysiology of acute coronary syndrome.
    Massberg S; Schulz C; Gawaz M
    Semin Vasc Med; 2003 May; 3(2):147-62. PubMed ID: 15199478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement links platelets to innate immunity.
    Nording H; Langer HF
    Semin Immunol; 2018 Jun; 37():43-52. PubMed ID: 29426568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of platelets in athero-thrombotic events.
    Freynhofer MK; Bruno V; Wojta J; Huber K
    Curr Pharm Des; 2012; 18(33):5197-214. PubMed ID: 22724408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial dysfunction, impaired endogenous platelet inhibition and platelet activation in diabetes and atherosclerosis.
    Schäfer A; Bauersachs J
    Curr Vasc Pharmacol; 2008 Jan; 6(1):52-60. PubMed ID: 18220940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet activation in essential hypertension: implications for antiplatelet treatment.
    Gkaliagkousi E; Passacquale G; Douma S; Zamboulis C; Ferro A
    Am J Hypertens; 2010 Mar; 23(3):229-36. PubMed ID: 20094035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship of platelet reactivity to the occurrence of post-stenting ischemic events: emergence of a new cardiovascular risk factor.
    Gurbel PA
    Rev Cardiovasc Med; 2006; 7 Suppl 4():S20-8. PubMed ID: 17224887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet therapy and vascular disease: an update.
    Buch MH; Prendergast BD; Storey RF
    Ther Adv Cardiovasc Dis; 2010 Aug; 4(4):249-75. PubMed ID: 21303843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelets as Mediators of Thromboinflammation in Chronic Myeloproliferative Neoplasms.
    Marin Oyarzún CP; Heller PG
    Front Immunol; 2019; 10():1373. PubMed ID: 31258539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.